Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Chemically Tailored Transcription Factor Proteins for Dissecting Gene Expression Regulation

Project description

Custom-built proteins to outsmart cancer

Transcription factors, the proteins that switch genes on and off, are the cell’s master regulators. When they malfunction, they can trigger uncontrolled cell growth, leading to cancer. Scientists are studying how these proteins are regulated and how to stop them when they go wrong. In this context, the ERC-funded ProTailor project aims to study how subtle chemical changes, known as post-translational modifications, affect gene activity. To do this, it will build customised versions of transcription factors. Using cutting-edge chemistry and molecular tools, the project seeks to map how these tweaks drive cancer. The findings will open the door to smarter, more precise therapies in the future.

Objective

The aberrant function of oncogenic transcription factors (TFs) is one of the most common drivers in human cancers, yet the mechanisms underlying their deregulation and targeting remain elusive. Understanding pathways that regulate TFs function has the potential to develop novel therapeutic compounds to target tumorigenesis. The overreaching goal of ProTailor is to develop ground-breaking modified TFs to understand gene expression regulation mechanisms and set the foundation for therapeutic opportunities to study and target human tumorigenesis.
Aim 1: I will develop novel synthetic strategies to prepare site-specifically modified oncogenic TF analogs bearing defined post-translational modifications (PTMs) to decipher the molecular role of PTMs in regulating gene expression. I will combine chemoselective peptide ligation, and orthogonal transformations, along with high-throughput screening to probe the molecular role of essential PTMs on gene recognition, interaction, and cancer-related oncogene expression.
Aim 2: I will generate libraries of chromatinized-DNA probes to investigate the interactions of modified TFs with packed DNA, aiming to understand how PTMs modulate TF-DNA interactions, accessibility, and influence gene expression regulation. I will probe the crosstalk between TF-PTMs, epigenetic modifications, and chromatin binding sites to unravel the mechanisms underlying gene recognition and interactions.
Aim 3: I will design photoreactive TF probes to map the regulatory role of PTMs in the interactions of oncogenic TF analogs with transcriptional machinery. I will deliver the synthetic TF probes to cancer cells and dissect the mechanisms by which PTMs modulate biomolecular interactions and unravel potential PTM markers associated with oncogene expression.
ProTailor will provide novel and powerful research tools to understand gene expression regulation mechanisms and lay the groundwork for therapeutic strategies to investigate and target human tumorigenesis.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

TEL AVIV UNIVERSITY
Net EU contribution
€ 1 786 250,00
Total cost
€ 1 786 250,00

Beneficiaries (1)